Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Optic Neuromyelitis Spectrum Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07595965
What this trial is testing

Evaluate the Safety and Tolerability of CE211NS21 in Patients With AQP4-IgG-positive NMOSD Relapse

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Relapse
Corestemchemon, Inc. 6
Very early researchLooking for participantsNCT06939166
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia GravisMultiple Sclerosis+2 more
Tianjin Huanhu Hospital 12
Not applicableLooking for participantsNCT06398158
What this trial is testing

Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica
University of Texas Southwestern Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT04670770
What this trial is testing

An Open Label Study of the Effects of SHR1459 in NMOSDs Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Reistone Biopharma Company Limited 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738952
What this trial is testing

Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Kyushu University 7
Testing effectiveness (Phase 2)Ended earlyNCT05356858
What this trial is testing

An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

Who this might be right for
Neuromyelitis Optica
Xuanwu Hospital, Beijing 6
Early research (Phase 1)Looking for participantsNCT06680037
What this trial is testing

Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Who this might be right for
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. 100
Not applicableStudy completedNCT05840055
What this trial is testing

ACT with NMOSD Patients and Caregivers Pilot Study

Who this might be right for
NMO Spectrum Disorder
Thomas Jefferson University 43
Large-scale testing (Phase 3)Ended earlyNCT01892345
What this trial is testing

Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 143
Large-scale testing (Phase 3)Active Not RecruitingNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT07184840
What this trial is testing

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital 110
Large-scale testing (Phase 3)Study completedNCT04660539
What this trial is testing

Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Hoffmann-La Roche 119
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Large-scale testing (Phase 3)Looking for participantsNCT06413654
What this trial is testing

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd 132
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Not applicableLooking for participantsNCT05017142
What this trial is testing

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Who this might be right for
Optic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more
University of Bern 500
Testing effectiveness (Phase 2)Looking for participantsNCT07022197
What this trial is testing

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

Who this might be right for
Chronic Inflammatory Demyelinating PolyradiculoneuropathyNMO Spectrum DisorderMyasthenia Gravis+1 more
Tianjin Medical University General Hospital 27
Not applicableLooking for participantsNCT07202494
What this trial is testing

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)+7 more
Assistance Publique Hopitaux De Marseille 700
Not applicableStudy completedNCT06888622
What this trial is testing

BLAZE-Limiting Approach in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Huashan Hospital 9
Not applicableStudy completedNCT07164924
What this trial is testing

Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisordersFertility
University Hospital, Clermont-Ferrand 800
Next Page